Akebia Therapeutics, Inc. AKBA
- ebribafusp — C3 Glomerulopathy Phase 2
- ebribafusp — IgA Nephropathy Phase 2
- ebribafusp — Lupus Nephritis Phase 2
Factor H (1 companies · 3 programs)
Companies with an active program directed at Factor H.
Companies with an active program directed at Factor H.